CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 615 enrolled
Drug / intervention
Usual care +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04248816
NCT04248816N/ACompleted

Increasing Surveillance Rates for Hepatocellular Carcinoma Among Cirrhotic Patients

University of Pennsylvania·interventional·Posted Jan 30, 2020·Updated Feb 14, 2023

In Brief

A clinical study evaluating Usual care, Opt-out, and 1 other intervention for Hepatocellular Carcinoma and Cirrhosis. Completed, enrolled 615 participants across 1 site.

Detailed Summary

This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular carcinoma (HCC).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 30, 2020
Enrollment StartNov 19, 2020
Primary CompletionNov 26, 2021
Study CompletionFeb 14, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.4 years ago

Interventions

Usual carebehavioral

Subjects will receive outreach through their providers as is standard of care.

Opt-outbehavioral

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip for them to get it done at a health system facility.

Opt-out + Incentivebehavioral

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip plus an unconditional $20 incentive for them to get it done at a health system facility.